mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |